Japan Veterinary Ophthalmic Drugs Market Size, Share, By Drug (Antibiotics, NSAIDs, Corticosteroids, Lubricants/Artificial Tears, Analgesics/Pain Relievers, and Others), By Distribution Channel (Veterinary Hospitals & Clinics, Pet Speciality Stores, E-Commerce, and Others), Japan Veterinary Ophthalmic Drugs Market Insights, Industry Trend, Forecasts to 2035.
Industry: Healthcare
Japan Veterinary Ophthalmic Drugs Market Insights Forecasts to 2035
- Japan Veterinary Ophthalmic Drugs Market Size 2024: USD 43.2 Mn
- Japan Veterinary Ophthalmic Drugs Market Size 2035: USD 116.7 Mn
- Japan Veterinary Ophthalmic Drugs Market CAGR 2024: 9.45%
- Japan Veterinary Ophthalmic Drugs Market Segments: Drug and Distribution Channel
Get more details on this report -
The veterinary ophthalmic drugs market refers to a range of medications used in animals for the diagnosis, treatment, and management of ocular disorders. These drugs are used in both companion and livestock animals to protect the eyes from infection, relieve pain, reduce inflammation, and maintain overall ocular health.
In Japan, Senju Pharmaceutical, in collaboration with DS Pharma Animal Health, launched IDU Senju, a novel ophthalmic eye drop containing idoxuridine as its active ingredient. This product is the only drug approved in Japan for the specific treatment of eye disorders caused by feline herpesvirus, highlighting ongoing product innovation in the veterinary ophthalmology space.
The Japanese government plays an active role in collecting data and monitoring antimicrobial resistance related to veterinary antimicrobial use (AMU). It supports the Japan Veterinary Antimicrobial Resistance Monitoring (JVARM) program and its associated initiatives. This monitoring includes antimicrobial sales and usage data, encompassing drugs used for ocular infections, and aligns with international efforts to combat antimicrobial resistance and promote the rational use of veterinary medicines.
The growing trend of companion animal ownership, along with increased spending on veterinary care, is driving demand for innovative, targeted, and long-acting ophthalmic therapeutics across both developed and developing markets.
Japan Veterinary Ophthalmic Drugs Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 43.2 Million |
| Forecast Period: | 2025-2035 |
| Forecast Period CAGR 2025-2035 : | CAGR Of 9.45% |
| 2035 Value Projection: | USD 116.7 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 189 |
| Tables, Charts & Figures: | 163 |
| Segments covered: | By Drug,By Distribution Channel |
| Companies covered:: | Senju Pharmaceutical Co., Ltd., Ds Pharma Animal Health Co., Ltd., Santen Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd., Rohto Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Co., Ltd., Astellas Pharma Inc.,and Other key players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The Japan veterinary ophthalmic drugs market share is classified into drugs and distribution channels.
By Drug:
The Japan veterinary ophthalmic drugs market is divided by drug into antibiotics, NSAIDs, corticosteroids, lubricants/artificial tears, analgesics/pain relievers, and other drugs. Among these, the lubricants/artificial tears segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Lubricants and artificial tears have a primary role as a result of their repeated application in chronic dry eye treatment, preventive eye care, ageing pets, and their very safe and long-lasting use without rigorous regulatory limitations.
By Distribution Channel:
The Japan veterinary ophthalmic drugs market is divided by distribution channel into veterinary hospitals & clinics, pet speciality stores, e-commerce, and others. Among these, the veterinary hospitals & clinics segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Veterinary Hospitals and Clinics are the leading place for sales of ophthalmic drugs, as most of them need a doctor's diagnosis or a prescription, which guarantees treatment according to the pets' needs, thus higher efficacy and trust, which makes clinics the main distribution channel in Japan.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the Japan veterinary ophthalmic drugs market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in Japan Veterinary Ophthalmic Drugs Market:
- Senju Pharmaceutical Co., Ltd.
- DS Pharma Animal Health Co., Ltd.
- Santen Pharmaceutical Co., Ltd.
- Nihon Nohyaku Co., Ltd.
- Rohto Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Daiichi Sankyo Co., Ltd.
- Astellas Pharma Inc.
- Other key players
Key Target Audience
- Market Players
- Investors
- End Users
- Government Authorities
- Consulting and Research Firms
- Venture Capitalists
- Value-Added Resellers (VARs)
Market Segmentation
This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan veterinary ophthalmic drugs market based on the following segments:
Japan Veterinary Ophthalmic Drugs Market, by Drug Type
- Antibiotics
- NSAIDs
- Corticosteroids
- Lubricants / Artificial Tears
- Analgesics / Pain Relievers
- Others
Japan Veterinary Ophthalmic Drugs Market, by Distribution Channel
- Veterinary Hospitals & Clinics
- Pet Specialty Stores
- E-Commerce
- Others
Frequently Asked Questions (FAQ)
-
Q: What is the Japan veterinary ophthalmic drugs market size?A: Japan veterinary ophthalmic drugs market is expected to grow from USD 43.2 million in 2024 to USD 116.7 million by 2035, growing at a CAGR of 9.45% during the forecast period 2025-2035.
-
Q: What are the key growth drivers of the market?A: Market growth is driven by increasing incidence of ocular disorders in pets, the heightened awareness of animal eye health, and the resulting larger investments in advanced veterinary care are some of the major factors that are driving the Japan veterinary ophthalmic drugs market. Besides, the gradual yet continuous growth of the market is fortified by the stringent regulatory control, the presence of speciality ophthalmic products, the opening up of veterinary clinics, and the need for eye treatments that are targeted, safe, and effective.
-
Q: What factors restrain the Japan veterinary ophthalmic drugs market?A: Constraints include the high cost of treatment and products, as well as the strenuous process for getting regulatory approvals. In addition, the unavailability of specialized veterinary ophthalmologists and the policies on the cautious use of antibiotics that might slow the adoption of products and limit the growth of the market are also factors restraining the market.
-
Q: How is the market segmented by drug?A: The market is segmented into antibiotics, NSAIDs, corticosteroids, lubricants/artificial tears, analgesics/pain relievers, and others.
-
Q: Who are the key players in the Japan veterinary ophthalmic drugs market?A: Key companies Senju Pharmaceutical Co., Ltd., DS Pharma Animal Health Co., Ltd., Santen Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd., Rohto Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Co., Ltd., Astellas Pharma Inc., and Others.
-
Q: Who are the target audiences for this market report?A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?